J Pathol Transl Med.
2020 Mar;54(2):196-196. 10.4132/jptm.2020.02.17.
Correction of acknowledgments: PD-L1 testing in non-small cell lung cancer: past, present, and future
- Affiliations
-
- 1Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea
- 2Department of Pathology, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2501612
- DOI: http://doi.org/10.4132/jptm.2020.02.17
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
- Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parameters
- Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation–Positive Lung Adenocarcinoma
- Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer
- Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer: Past, Present, and Hope for the Future
